- Home
- SGU vs STRO Comparison
SGU vs STRO Comparison
Compare SGU & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGU | STRO |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.4M | 381.1M |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SGU | STRO |
|---|---|---|
| Price | $12.80 | $20.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $31.33 |
| AVG Volume (30 Days) | 19.4K | ★ 263.7K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.90% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,784,418,000.00 | $38,419,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.70 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.37 | $0.72 |
| 52 Week High | $13.53 | $43.85 |
Technical Indicators
Market Signals| Indicator | SGU | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 57.66 | 39.40 |
| Support Level | $12.34 | $18.74 |
| Resistance Level | $12.89 | $26.35 |
| Average True Range (ATR) | 0.20 | 1.45 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 95.92 | 31.83 |
Price Performance
Historical ComparisonAbout SGU Star Group L.P.
Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.